Cilostazol: a potential therapeutic option to prevent in-stent restenosis. - Suppr | 超能文献

Cilostazol: a potential therapeutic option to prevent in-stent restenosis.

作者信息

Dihu Jamil B, Abudayyeh Islam, Saudye Hammad A, Gurujal Ravi

出版信息

J Am Coll Cardiol. 2011 May 17;57(20):2035-6. doi: 10.1016/j.jacc.2011.01.022.

DOI:10.1016/j.jacc.2011.01.022

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Cilostazol: a potential therapeutic option to prevent in-stent restenosis.

J Am Coll Cardiol. 2011 May 17;57(20):2035-6. doi: 10.1016/j.jacc.2011.01.022.

2

A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial.一项随机、双盲、多中心对比研究，旨在比较三联抗血小板治疗与双联抗血小板治疗在减少长病变药物洗脱支架置入后再狭窄方面的疗效：来自 DECLARE-LONG II 试验（西洛他唑治疗可降低长病变患者药物洗脱支架置入后晚期再狭窄）的结果。

J Am Coll Cardiol. 2011 Mar 15;57(11):1264-70. doi: 10.1016/j.jacc.2010.10.035.

3

Differential impact of cilostazol on restenosis according to implanted stent type (from a pooled analysis of three DECLARE randomized trials).根据植入支架类型的不同，西洛他唑对再狭窄的影响（来自三个 DECLARE 随机试验的汇总分析）。

Am J Cardiol. 2013 Nov 1;112(9):1328-34. doi: 10.1016/j.amjcard.2013.06.010. Epub 2013 Jul 24.

4

Randomized Angiographic and Intravascular Ultrasound Comparison of Dual-Antiplatelet Therapy vs Triple-Antiplatelet Therapy to Reduce Neointimal Tissue Proliferation in Diabetic Patients.双抗血小板治疗与三联抗血小板治疗减少糖尿病患者新生内膜组织增殖的随机血管造影和血管内超声比较

J Invasive Cardiol. 2017 Mar;29(3):76-81.

5

Addition of cilostazol to aspirin and a thienopyridine for prevention of restenosis after coronary artery stenting: a meta-analysis.在冠状动脉支架置入术后加用西洛他唑、阿司匹林和噻氯匹定预防再狭窄：一项荟萃分析。

J Clin Pharmacol. 2010 Apr;50(4):415-21. doi: 10.1177/0091270009338940. Epub 2010 Jan 16.

6

In-stent restenosis.支架内再狭窄。

Cardiovasc Ther. 2011 Jun;29(3):190-8. doi: 10.1111/j.1755-5922.2010.00155.x. Epub 2010 Apr 9.

7

Stent thrombosis with drug-eluting and bare-metal stents.药物洗脱支架和裸金属支架相关的支架内血栓形成

Lancet. 2012 Aug 18;380(9842):646; author reply 646-7. doi: 10.1016/S0140-6736(12)61365-8.

8

Comparison of Triple antiplatelet therapy and dual antiplatelet therapy in patients at high risk of restenosis after drug-eluting stent implantation (from the DECLARE-DIABETES and -LONG Trials).比较药物洗脱支架植入术后高再狭窄风险患者的三联抗血小板治疗与双联抗血小板治疗（来自 DECLARE-DIABETES 和 -LONG 试验）。

Am J Cardiol. 2010 Jan 15;105(2):168-73. doi: 10.1016/j.amjcard.2009.08.667. Epub 2009 Dec 3.

9

Coronary stent strut fracture after drug-eluting stent implantation: a newly recognized complication.药物洗脱支架置入后冠状动脉支架梁断裂：一种新认识的并发症。

Int J Cardiol. 2009 Feb 6;132(1):121-2. doi: 10.1016/j.ijcard.2007.07.011. Epub 2007 Aug 10.

10

The Effect of Cilostazol on the Angiographic Outcome of Drug-Eluting Coronary Stents Angiographic Analysis of the CILON-T (Influence of CILostazol-Based Triple Antiplatelet Therapy ON Ischemi Complication after Drug-Eluting StenT Implantation) Trial.西洛他唑对药物洗脱冠状动脉支架血管造影结果的影响：CILON-T（基于西洛他唑的三联抗血小板治疗对药物洗脱支架植入后缺血并发症的影响）试验的血管造影分析

Int Heart J. 2017 Dec 12;58(6):853-860. doi: 10.1536/ihj.16-332. Epub 2017 Nov 8.

引用本文的文献

1

Augmented AMPK activity inhibits cell migration by phosphorylating the novel substrate Pdlim5.增强的AMPK活性通过磷酸化新底物Pdlim5来抑制细胞迁移。

Nat Commun. 2015 Jan 30;6:6137. doi: 10.1038/ncomms7137.

2

Effect of pioglitazone on in-stent restenosis after coronary drug-eluting stent implantation: a meta-analysis of randomized controlled trials.

PLoS One. 2014 Oct 3;9(10):e109614. doi: 10.1371/journal.pone.0109614. eCollection 2014.

3

Cilostazol prevents progression of asymptomatic carotid artery stenosis in patients with contralateral carotid artery stenting.西洛他唑可预防对侧颈动脉支架置入术后无症状性颈动脉狭窄患者的进展。

AJNR Am J Neuroradiol. 2012 Aug;33(7):1262-6. doi: 10.3174/ajnr.A2955. Epub 2012 Feb 9.